Systemic glucose variability predicts cerebral metabolic distress and mortality after subarachnoid hemorrhage: a retrospective observational study

Pedro Kurtz(D’Or Institute for Research and Education), Stephan A. Mayer(Westchester Medical Center), Raimund Helbok(Johannes Kepler University of Linz), E. Sander Connolly, Jan Claassen(Columbia University), J. Michael Schmidt(University of Southern California), Luis Fernández‐Salazar(Hospital Clínico Universitario de Valladolid), Neeraj Badjatia(University of Maryland, Baltimore), Kiwon Lee(Columbia University), Mary Presciutti(Columbia University Irving Medical Center), R. M. Stuart
Critical Care
May 4, 2014
10.1186/cc13857
Cited by 75

Related Papers

Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study
|The Lancet|2020|2.3k
Guidelines for the Evaluation and Management of Status Epilepticus
|Neurocritical Care|2012|1.6k
Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021
|JAMA|2022|909
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
|Blood|2020|776
A management algorithm for patients with intracranial pressure monitoring: the Seattle International Severe Traumatic Brain Injury Consensus Conference (SIBICC)
|Intensive Care Medicine|2019|623